Convalescent plasma as a potential therapy for COVID-19

doi:10.1016/S1473-3099(20)30141-9

Comment

. 2020 Apr;20(4):398-400.

doi: 10.1016/S1473-3099(20)30141-9. Epub 2020 Feb 27.

Convalescent plasma as a potential therapy for COVID-19

Long Chen¹, Jing Xiong¹, Lei Bao¹, Yuan Shi²

Affiliations

¹ Department of Neonatology, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing, 400014, China; National Clinical Research Center for Child Health and Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing, 400014, China; China International Science and Technology Cooperation base of Child development and Critical Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing, 400014, China; Children's Hospital of Chongqing Medical University; Chongqing Key Laboratory of Pediatrics, Chongqing, 400014, China.
² Department of Neonatology, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing, 400014, China; National Clinical Research Center for Child Health and Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing, 400014, China; China International Science and Technology Cooperation base of Child development and Critical Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing, 400014, China; Children's Hospital of Chongqing Medical University; Chongqing Key Laboratory of Pediatrics, Chongqing, 400014, China. Electronic address: petshi530@vip.163.com.

PMID: 32113510
PMCID: PMC7128218
DOI: 10.1016/S1473-3099(20)30141-9

Comment

Convalescent plasma as a potential therapy for COVID-19

Long Chen et al. Lancet Infect Dis. 2020 Apr.

. 2020 Apr;20(4):398-400.

doi: 10.1016/S1473-3099(20)30141-9. Epub 2020 Feb 27.

Authors

Long Chen¹, Jing Xiong¹, Lei Bao¹, Yuan Shi²

Affiliations

¹ Department of Neonatology, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing, 400014, China; National Clinical Research Center for Child Health and Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing, 400014, China; China International Science and Technology Cooperation base of Child development and Critical Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing, 400014, China; Children's Hospital of Chongqing Medical University; Chongqing Key Laboratory of Pediatrics, Chongqing, 400014, China.
² Department of Neonatology, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing, 400014, China; National Clinical Research Center for Child Health and Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing, 400014, China; China International Science and Technology Cooperation base of Child development and Critical Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing, 400014, China; Children's Hospital of Chongqing Medical University; Chongqing Key Laboratory of Pediatrics, Chongqing, 400014, China. Electronic address: petshi530@vip.163.com.

PMID: 32113510
PMCID: PMC7128218
DOI: 10.1016/S1473-3099(20)30141-9

No abstract available

PubMed Disclaimer

Comment in

Appropriate selection of convalescent plasma donors for COVID-19.
Tedder RS, Semple MG. Tedder RS, et al. Lancet Infect Dis. 2021 Feb;21(2):168-169. doi: 10.1016/S1473-3099(20)30470-9. Epub 2020 Jun 15. Lancet Infect Dis. 2021. PMID: 32553190 Free PMC article. No abstract available.

Comment on

The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis.
Mair-Jenkins J, Saavedra-Campos M, Baillie JK, Cleary P, Khaw FM, Lim WS, Makki S, Rooney KD, Nguyen-Van-Tam JS, Beck CR; Convalescent Plasma Study Group. Mair-Jenkins J, et al. J Infect Dis. 2015 Jan 1;211(1):80-90. doi: 10.1093/infdis/jiu396. Epub 2014 Jul 16. J Infect Dis. 2015. PMID: 25030060 Free PMC article. Review.

Cited by

Fruitful Neutralizing Antibody Pipeline Brings Hope To Defeat SARS-Cov-2.
Renn A, Fu Y, Hu X, Hall MD, Simeonov A. Renn A, et al. Trends Pharmacol Sci. 2020 Nov;41(11):815-829. doi: 10.1016/j.tips.2020.07.004. Epub 2020 Jul 31. Trends Pharmacol Sci. 2020. PMID: 32829936 Free PMC article. Review.
Pandemic preparedness planning in peacetime: what is missing?
Osterhaus A, Mackenzie J. Osterhaus A, et al. One Health Outlook. 2020;2(1):19. doi: 10.1186/s42522-020-00027-2. Epub 2020 Aug 14. One Health Outlook. 2020. PMID: 32835171 Free PMC article. No abstract available.
Origin, Pathogenesis, Diagnosis and Treatment Options for SARS-CoV-2: A Review.
Sajjad H, Majeed M, Imtiaz S, Siddiqah M, Sajjad A, Din M, Ali M. Sajjad H, et al. Biologia (Bratisl). 2021;76(9):2655-2673. doi: 10.1007/s11756-021-00792-z. Epub 2021 Jun 2. Biologia (Bratisl). 2021. PMID: 34092799 Free PMC article. Review.
Introduction on Coronavirus Disease (COVID-19) Pandemic: The Global Challenge.
Rezaei N, Ashkevarian S, Fathi MK, Hanaei S, Kolahchi Z, Ladi Seyedian SS, Rayzan E, Sarzaeim M, Vahed A, Mohamed K, Momtazmanesh S, Moradian N, Pirkoohi ZR, Sameeifar N, Yousefpour M, Sargoli S, Adiban S, Vahed A, Yazdanpanah N, Ziaei H, Saghazadeh A. Rezaei N, et al. Adv Exp Med Biol. 2021;1318:1-22. doi: 10.1007/978-3-030-63761-3_1. Adv Exp Med Biol. 2021. PMID: 33973169
Therapeutic Development in COVID-19.
Yang C, Huang Y, Liu S. Yang C, et al. Adv Exp Med Biol. 2021;1318:435-448. doi: 10.1007/978-3-030-63761-3_25. Adv Exp Med Biol. 2021. PMID: 33973193

See all "Cited by" articles

References

1. Holshue ML, DeBolt C, Lindquist S, et al. First case of 2019 novel coronavirus in the United States. N Engl J Med. 2020 doi: 10.1056/NEJMoa2001191. published online Jan 31. - DOI - PMC - PubMed
1. Lai ST. Treatment of severe acute respiratory syndrome. Eur J Clin Microbiol Infect Dis. 2005;24:583–591. - PMC - PubMed
1. Soo YO, Cheng Y, Wong R, et al. Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients. Clin Microbiol Infect. 2004;10:676–678. - PMC - PubMed
1. Cheng Y, Wong R, Soo YO, et al. Use of convalescent plasma therapy in SARS patients in Hong Kong. Eur J Clin Microbiol Infect Dis. 2005;24:44–46. - PMC - PubMed
1. WHO Use of convalescent whole blood or plasma collected from patients recovered from Ebola virus disease for transfusion, as an empirical treatment during outbreaks. 2014. http://apps.who.int/iris/rest/bitstreams/604045/retrieve

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- The Lens - Patent Citations Database

[1] Holshue ML, DeBolt C, Lindquist S, et al. First case of 2019 novel coronavirus in the United States. N Engl J Med. 2020 doi: 10.1056/NEJMoa2001191. published online Jan 31. - DOI - PMC - PubMed

[2] Holshue ML, DeBolt C, Lindquist S, et al. First case of 2019 novel coronavirus in the United States. N Engl J Med. 2020 doi: 10.1056/NEJMoa2001191. published online Jan 31. - DOI - PMC - PubMed

[3] Lai ST. Treatment of severe acute respiratory syndrome. Eur J Clin Microbiol Infect Dis. 2005;24:583–591. - PMC - PubMed

[4] Lai ST. Treatment of severe acute respiratory syndrome. Eur J Clin Microbiol Infect Dis. 2005;24:583–591. - PMC - PubMed

[5] Soo YO, Cheng Y, Wong R, et al. Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients. Clin Microbiol Infect. 2004;10:676–678. - PMC - PubMed

[6] Soo YO, Cheng Y, Wong R, et al. Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients. Clin Microbiol Infect. 2004;10:676–678. - PMC - PubMed

[7] Cheng Y, Wong R, Soo YO, et al. Use of convalescent plasma therapy in SARS patients in Hong Kong. Eur J Clin Microbiol Infect Dis. 2005;24:44–46. - PMC - PubMed

[8] Cheng Y, Wong R, Soo YO, et al. Use of convalescent plasma therapy in SARS patients in Hong Kong. Eur J Clin Microbiol Infect Dis. 2005;24:44–46. - PMC - PubMed

[9] WHO Use of convalescent whole blood or plasma collected from patients recovered from Ebola virus disease for transfusion, as an empirical treatment during outbreaks. 2014. http://apps.who.int/iris/rest/bitstreams/604045/retrieve

[10] WHO Use of convalescent whole blood or plasma collected from patients recovered from Ebola virus disease for transfusion, as an empirical treatment during outbreaks. 2014. http://apps.who.int/iris/rest/bitstreams/604045/retrieve

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Convalescent plasma as a potential therapy for COVID-19

Affiliations

Convalescent plasma as a potential therapy for COVID-19

Authors

Affiliations

Comment in

Comment on

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources